Trusopt (dorzolamide HCl ophthalmic solution, MSD) is a novel carbonic anhydrase inhibitor formulated for topical ophthalmic use. Unlike oral carbonic anhydrase inhibitors, Trusopt, which is administered topically, exerts its effects directly in the eye.